Hana Pharm Co Ltd banner
H

Hana Pharm Co Ltd
KRX:293480

Watchlist Manager
Hana Pharm Co Ltd
KRX:293480
Watchlist
Price: 8 240 KRW Market Closed
Market Cap: ₩146.4B

Wall St Price Targets

Price Forecast
Based on 3 analysts

+73% Upside
from ₩8 240 today

Hana Pharm Co Ltd (293480)’s 12-month stock price forecast through September 2027 has a consensus target of ₩14 280, implying 73% upside. The forecast is based on price targets from 3 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Hana Pharm Co Ltd yet.

Hana Pharm Co Ltd Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Hana Pharm Co Ltd's stock price target?
Price Target
14 280 KRW

According to Wall Street analysts, the average 1-year price target for Hana Pharm Co Ltd is 14 280 KRW with a low forecast of 14 140 KRW and a high forecast of 14 700 KRW.

What is the Revenue forecast for Hana Pharm Co Ltd?
Projected CAGR
7%

Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 7%.

What is the Gross Profit forecast for Hana Pharm Co Ltd?
Projected CAGR
6%

Over the last 8 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 6%.

What is the Operating Income forecast for Hana Pharm Co Ltd?
Projected CAGR
5%

Over the last 8 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 3 years is 5%.

What is the Pre-Tax Income forecast for Hana Pharm Co Ltd?
Projected CAGR
19%

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been -6%. The projected CAGR for the next 3 years is 19%.

What is the Net Income forecast for Hana Pharm Co Ltd?
Projected CAGR
41%

Over the last 8 years, the compound annual growth rate for Net Income has been -12%. The projected CAGR for the next 3 years is 41%.

Back to Top